thalidomide has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 65-year-old male with multiple myeloma received chemotherapy which included cyclophosphamide, thalidomide and dexamethasone." | 1.39 | Negative chronotropic effects and coronary ischaemic abnormalities following thalidomide therapy. ( Ali, A; Hothi, SS; Malik, N; Thompson, A, 2013) |
| "Sustained ventricular tachycardia possibly owing to thalidomide treatment." | 1.34 | Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia. ( Ballanti, S; Berchicci, L; Bolli, N; Capolsini, I; Giordano, G; Lotti, F; Mastrodicasa, E; Merigiola, C; Tabilio, A, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, A | 1 |
| Hothi, SS | 1 |
| Thompson, A | 1 |
| Malik, N | 1 |
| Ballanti, S | 1 |
| Mastrodicasa, E | 1 |
| Bolli, N | 1 |
| Lotti, F | 1 |
| Capolsini, I | 1 |
| Berchicci, L | 1 |
| Merigiola, C | 1 |
| Giordano, G | 1 |
| Tabilio, A | 1 |
2 other studies available for thalidomide and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Negative chronotropic effects and coronary ischaemic abnormalities following thalidomide therapy.
Topics: Aged; Bradycardia; Coronary Vasospasm; Electrocardiography; Humans; Immunosuppressive Agents; Male; | 2013 |
Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia.
Topics: Aged; Angiogenesis Inhibitors; Humans; Leukemia, Plasma Cell; Male; Tachycardia, Ventricular; Thalid | 2007 |